Clinical Trial Update: Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma [Phase 2]

View source ↗

Summary

Phase II study overview for Mesothelioma Stratified Therapy (MiST), a multi-drug regimen trial in malignant mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma

Snippet

Sponsor: University of Leicester | Conditions: Mesothelioma, Malignant | Phase 2 | Status: UNKNOWN